Medicines for Ireland has suggested that “a question mark hangs over long term patient access to medicines in Ireland” as the country experiences the direct impact of Brexit on imports and exports of medicines and medical devices since the start of January. As the pressure on the supply chain builds, the off-patent industry association has urged all stakeholders to “organize sustainable solutions quickly.”
“As the supplier of the majority of medicines in Ireland to both the Health Service Executive and to patients directly,...
